Wutah pendapatan taun lumaku: Portage Biotech Corp (PRTG)

Logo perusahaan publik portagebiotech.com (PRTG)

Despite a lack of profitability and a reliance on investment, Portage Biotech Inc. (PRTG) operates within the protected medical innovation sector, which remains insulated from macroeconomic fluctuations. The rolling 12-month sales growth rate compared to the previous year demonstrates current trends, where the 0.00 mark reflects the latest data. Portage Biotech Inc. (PRTG) is developing immunotherapy to combat solid tumors, targeting the checkpoint inhibitor market and patients with resistant forms of cancer.

Portage Biotech Inc. (PRTG): Wutah pendapatan YoY sajrone 12 wulan kepungkur saka 11.02.2024 nganti 20.02.2024

Portage Biotech Inc. - rincian analitis lan metrik utama (PRTG)

- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
Ringkesan analitik perusahaan:Portage
Produk merek Portage Biotech Corp

This indicator measures revenue dynamics over the last twelve months relative to the same period last year, allowing for an assessment of the stability of customer demand and the pace of business expansion. Analyzing the annual sales growth rate over a 12-month period is critically important for Portage Biotech Inc. (PRTG), as turnover volatility during the NKT-asset development stage may signal risks or, conversely, an increase in investment attractiveness for acquisition by pharma behemoths.

Karo sapa Portage Biotech Inc. saingan

Incyte Pharma - Wutah dodolan YoY sajrone rolas wulan kepungkur|HUTCHMED Corp - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Nuvation Bio Inc.|DAWN: Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Monopar Pharma MNPR|Wutah pendapatan YoY sajrone 12 wulan kepungkur INBX|Wutah pendapatan taun lumaku I-Mab Biopharma IMAB|Wutah pendapatan YoY sajrone 12 wulan kepungkur FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Nuvectis Pharma, Inc. - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur CHRS (Coherus BioSciences)|Corbus Pharma - Wutah dodolan YoY (TTM)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur CRDF (cardiffoncology.com)|BYSI: Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku BioAtla Corp (BCAB)|Wutah dodolan YoY sajrone rolas wulan kepungkur Lixte Biotechnology Holdings, Inc.|CTXR: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) CLRB|Wutah dodolan YoY (TTM) BioLineRx Corporation (BLRX)|Wutah dodolan YoY sajrone rolas wulan kepungkur Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Wutah dodolan taun lumaku|KZIA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Silexion Therapeutics|NuCana plc (NCNA) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur Chimerix, Inc|Wutah pendapatan YoY sajrone 12 wulan kepungkur CYCC|Wutah pendapatan YoY sajrone 12 wulan kepungkur G1 Therapeutics (GTHX)|Wutah dodolan YoY sajrone rolas wulan kepungkur Kronos Bio Corporation (KRON)|Kintara - Wutah dodolan YoY sajrone 12 wulan kepungkur|Oncternal Therapeutics, Inc. - Wutah pendapatan YoY sajrone 12 wulan kepungkur